Home NDC 59137-335 GRAFAPEX
Product NDC 59137-335
11-digit product format 591370335
Labeler code 59137
Product ID 59137-335_2d06b03c-17aa-0492-e063-6294a90abd8f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name treosulfan
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Medexus Pharma, Inc.
Application NDA214759
Marketing category NDA
Marketing start 2025-01-28
Substance TREOSULFAN
Active strength 1000 mg/g
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214759-001 GRAFAPEX TREOSULFAN 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 N214759-002 GRAFAPEX TREOSULFAN 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214759-001 7199162 2026-10-12 U-4142 2025-02-20 N214759-002 7199162 2026-10-12 U-4142 2025-02-20
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214759-001 GRAFAPEX 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214759-002 GRAFAPEX 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214759-001 GRAFAPEX 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214759-002 GRAFAPEX 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214759-001 GRAFAPEX 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214759-002 GRAFAPEX 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214759-001 GRAFAPEX 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214759-002 GRAFAPEX 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214759-001 GRAFAPEX 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214759-002 GRAFAPEX 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 b8a1b40f171c…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214759-001 GRAFAPEX 1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214759-002 GRAFAPEX 5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-01-21 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214759-001 7199162 2026-03-21 U-4142 2025-02-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214759-002 7199162 2026-03-21 U-4142 2025-02-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214759-001 7199162 2026-03-21 U-4142 2025-02-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214759-002 7199162 2026-03-21 U-4142 2025-02-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214759-001 7199162 2026-03-21 U-4142 2025-02-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214759-002 7199162 2026-03-21 U-4142 2025-02-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214759-001 7199162 2025-10-12 U-4142 2025-02-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214759-002 7199162 2025-10-12 U-4142 2025-02-20 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214759-001 7199162 2026-10-12 U-4142 2025-02-20 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214759-002 7199162 2026-10-12 U-4142 2025-02-20 a50c72e98297…
Observed Orange Book exclusivity history# Additional Listing Data#
Finished product Yes
Brand name base GRAFAPEX
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TREOSULFAN 1000 mg/g
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination CO61ER3EPI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2703570 Internal RxNorm lookup 2703575 Internal RxNorm lookup 2703577 Internal RxNorm lookup 2703579 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59137-335-01 GRAFAPEX 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 1 59137-335-01 GRAFAPEX 1 g in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59137-335 GRAFAPEX (TREOSULFAN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEDEXUS PHARMA, INC.] 1 Current NDC, 2 package rows 20250202_2d06b03c-17aa-0492-e063-6294a90abd8f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 59137-335-01 59137033501 1 VIAL in 1 CARTON (59137-335-01) / 1 g in 1 VIAL 1 vial 2025-01-28 No No Current